Perigon Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
13,926
+394
| +3% | +$42.3K | 0.03% | 392 |
|
|
2025
Q1 | $1.37M | Buy |
13,532
+996
| +8% | +$100K | 0.04% | 382 |
|
|
2024
Q4 | $1.23M | Sell |
12,536
-3,987
| -24% | -$391K | 0.03% | 398 |
|
|
2024
Q3 | $1.38M | Buy |
16,523
+5,544
| +50% | +$465K | 0.04% | 352 |
|
|
2024
Q2 | $845K | Sell |
10,979
-202
| -2% | -$15.6K | 0.02% | 409 |
|
|
2024
Q1 | $766K | Buy |
11,181
+311
| +3% | +$21.3K | 0.02% | 430 |
|
|
2023
Q4 | $628K | Sell |
10,870
-660
| -6% | -$38.2K | 0.02% | 440 |
|
|
2023
Q3 | $609K | Buy |
11,530
+538
| +5% | +$28.4K | 0.02% | 398 |
|
|
2023
Q2 | $595K | Buy |
10,992
+2,652
| +32% | +$143K | 0.02% | 415 |
|
|
2023
Q1 | $417K | Buy |
8,340
+371
| +5% | +$18.6K | 0.02% | 436 |
|
|
2022
Q4 | $369K | Buy |
7,969
+1,494
| +23% | +$69.1K | 0.02% | 468 |
|
|
2022
Q3 | $251K | Buy |
+6,475
| New | +$251K | 0.02% | 473 |
|
|
2021
Q1 | – | Sell |
-2,176
| Closed | -$78K | – | 557 |
|
|
2020
Q4 | $78K | Buy |
+2,176
| New | +$78K | 0.01% | 600 |
|
|
2018
Q2 | – | Sell |
-28
| Closed | -$1K | – | 285 |
|
|
2018
Q1 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 608 |
|